#options

Collection of options news, found 1.291 news.

Illumina and Next Generation Genomic partner to launch VeriSeq™ NIPT Solution in Thailand

Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. ...

Pathway to critical and formidable goal of net-zero emissions by 2050 is narrow but brings huge benefits, according to IEA special report

The world has a viable pathway to building a global energy sector with net-zero emissions in 2050, but it is narrow ...

Bluestar Genomics closes $70M Series C funding, expands scientific advisory board

Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early ...

Frequency of flights dipped 90% owing to mudik ban

Flight frequency at Indonesia's airports plunged by 90 percent after the ban on mudik (Eid al-Fitr exodus) on May ...

Smiths Medical and Ivenix partner to revolutionize infusion management with first-ever comprehensive suite of infusion solutions in US healthcare market

Smiths Medical, a global medical device leader, today announced it has formed an exclusive partnership with Ivenix, ...

New World La Plume Niseko Resort to open in 2023

New World® Hotels & Resorts has been appointed by Hong Kong SAR-based real estate and development firm La Plume ...

MessageBird acquires US-based SparkPost for $600m, extends Series C and raises $1B to become world's largest omnichannel provider

MessageBird, the world’s leading global omnichannel communication platform, today announces it has entered into ...

US declares $3.5 million fund for Indonesia's vaccination endeavors

The United States Mission in Indonesia made an announcement on Tuesday to funnel further funding of US$3.5 million ...

RubrYc Therapeutics announces a research collaboration and license option agreement with Zai Labs

RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today ...

LintonPharm announces authorization from China health authority (NMPA) to proceed with a phase 1/2 trial evaluating catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

Digital Edge to expand platform footprint in South Korea

Digital Edge (Singapore) Holdings Pte. Ltd. (“Digital Edge” or the “Company”), a leading data center platform, ...

Walgreens announces further expansion of its financial services business strategy with InComm Payments

Walgreens today announced an agreement with InComm Payments, a leading global payments technology company, to provide ...

President witnesses COVID-19 vaccination in Ambon

President Joko Widodo (Jokowi) observed the COVID-19 vaccination conducted for public service officers, religious ...

Liquid Instruments introduces Moku:Go – the robust lab education solution for the next generation of scientists and engineers

Today, Liquid Instruments, an innovator in precision software-defined instrumentation, launched Moku:Go, a complete, ...

Ministry drafting three long-term climate change strategies

The Environment and Forestry Ministry is preparing three scenarios involving energy transition as part of long-term ...